BRWJX
Price
$25.37
Change
-$0.65 (-2.50%)
Updated
Feb 21 closing price
Net Assets
410.61M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

BRWJX vs GFACX

Header iconBRWJX vs GFACX Comparison
Open Charts BRWJX vs GFACXBanner chart's image
MFS Blended Research Growth Eq I
Price$25.37
Change-$0.65 (-2.50%)
VolumeN/A
Net Assets410.61M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
BRWJX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRWJX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRWJX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. BRWJX (411M). BRWJX pays higher dividends than GFACX: BRWJX (0.54) vs GFACX (0.00). BRWJX was incepted earlier than GFACX: BRWJX (9 years) vs GFACX (24 years). BRWJX is a more actively managed with annual turnover of: 64.00 vs. GFACX (31.00). BRWJX has a lower initial minimum investment than GFACX: BRWJX (0) vs GFACX (250). BRWJX annual gain was more profitable for investors over the last year : 18.90 vs. GFACX (10.15). BRWJX return over 5 years is better than : 60.90 vs. GFACX (32.83).
BRWJXGFACXBRWJX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD0.8352.98028%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets411M304B0%
Annual Yield % from dividends0.540.00-
Returns for 1 year18.9010.15186%
Returns for 3 years47.3817.69268%
Returns for 5 years60.9032.83185%
Returns for 10 yearsN/A55.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding